More than 1 year ago, President Obama signed into law the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). This legislation was the product of overwhelmingly bipartisan support and was lauded by many health care stakeholders because it repealed the unpopular sustainable growth rate (SGR) method for updating the Medicare physician fee schedule. As physicians well know, the SGR led to uncertainty, threats of major pay cuts, and annual corrections known as the "doc fix."
Also by Dr. Dowling: Is a ‘perfect storm’ heading for urology?
MACRA is most notable for its sweeping changes to the way health care will be reimbursed in the future, and many have awaited details of its implementation. Those details began to emerge on April 27, 2016, when the Centers for Medicare & Medicaid Services (CMS) released its proposed rule for implementing MACRA.
Have you read: What overpayments rule means for your practice
In a series of articles this year, I will examine what you need to know about the law, what the CMS proposed rule for implementation implies for the near and long-term future, and—when it is issued later this year—what the final rule means to your urology practice. (For more on the MACRA rollout, see "MIPS: A first look at how it will affect your practice," and "MACRA proposed rule brings new decisions")